CBER "COMPLETE REVIEW" LETTERS COULD REPLACE "APPROVABLE/NOT APPROVABLE"; INDUSTRY, FDA LIKELY TO ADDRESS "APPROVABLE" DECISIONS IN PDUFA REAUTHORIZATION
Executive Summary
FDA's Center for Biologics Evaluation & Research is using "complete review" letters to replace "approvable" or "not approvable" letters for non-user fee applications.